Browse studies

Find your next paid study

8 recruiting studies matching your filters

A Phase II Study of Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Background: Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths called papillomas to grow in the airway, most often in …

Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus Infection+3 more

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT07756840

Phase 2

A Phase 2a, Multi-Center, Placebo-Controlled, Double-Blinded, Randomized, Dose Ranging Study of the Preliminary Efficacy of DARE-HPV to Treat Persistent High-Risk Human Papillomavirus (HPV) Genital Infection

The goal of this clinical study is to learn if DARE-HPV can treat persistent high-risk human papillomavirus (hrHPV). The primary outcome will be if the genital…

Human Papilloma Virus (HPV)High-risk Human Papillomavirus Infection

Estimated

~$10 – $8,750

Daré Bioscience, Inc.NCT07601074

Phase 1

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule, in Subjects With Unresectable, Locally Advanced, or Metastatic Solid Tumors That Are Antigen-rich (START-001)

This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent and in co…

Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more

Estimated

~$10 – $8,750

Marengo Therapeutics, Inc.NCT05592626

Observational

NCI Cervical Cancer 'Last Mile' Initiative 'Self-Collection for HPV Testing to Improve Cervical Cancer Prevention' (SHIP) Trial LMI-001-A-S04

This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cer…

Cervical CarcinomaHuman Papillomavirus Infection

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT07281430

Observational

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by pra…

Human Papillomavirus Infection

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT06598475

Observational

Appalachian Voices for Health - Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Since 2019, the HPV working group of the University of Virginia Cancer Center's Southwest Virginia Community Advisory Board has developed and executed strategi…

Human Papillomavirus InfectionVaccination Hesitancy

Estimated

~$10 – $6,250

University of VirginiaNCT05860725

Phase 4

Prospective Observational Immunogenicity Trial of Gardasil-9 HPV Vaccine in People Living With Adequately Managed HIV

The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adul…

Papillomavirus VaccinesHuman Immunodeficiency VirusPapillomavirus Infection+4 more

Estimated

~$10 – $6,250

Louisiana State University Health Sciences Center in New OrleansNCT05266898

Phase 4

Open-Label Study of Zopapogene Imadenovec Retreatment and Vector Shedding Evaluation in Adult Patients With Recurrent Respiratory Papillomatosis

This open-label study evaluates safety, vector shedding, and retreatment efficacy of Zopapogene imadenovec (Zopa) in adults with recurrent respiratory papillom…

Recurrent Respiratory PapillomatosisPapillomavirus InfectionPapillomaviridae

Estimated

~$10 – $8,750

Precigen, IncNCT06538480